Clinical Trial

Vagal Stimulator to Reduce Nasogastric Tube Use

Recruiting
View on ClinicalTrials.gov →
Summary
Abdominal surgery, laparoscopic or open, is frequently performed at UPMC Shadyside hospital. One of the most frequent complications following abdominal surgery is a postoperative ileus. Although postoperative ileus may be the result of obstruction or leakage, in most cases postoperative ileus (POI) is the result of local irritation because of fluid overload, exogenous opioids, neurohormonal dysfunction, gastrointestinal stretch, local bleeding and inflammation. POI usually lasts between 2 to 7 days. In most cases, a nasogastric tube (NG tube) is used to relieve that gastric pressure until the resolution of the POI. The placement of a NG tube can lead to a local trauma, bleeding and pain. Pain represents a major complaint among those with POI, often contributing to prolonged hospital stays.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-10-16; most recent amendment 2025-12-11.
Status change: Not Yet Recruiting → Recruiting 2024-12-11
Trial Details
NCT Number NCT06648759
Lead Sponsor Jacques E. Chelly
Conditions Nasogastric Tube Intubation
Enrollment 60 participants
Start Date 2024-12-04
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-17